- Home
- DIBS vs HUMA Comparison
DIBS vs HUMA Comparison
Compare DIBS & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DIBS | HUMA |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.3M | 182.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DIBS | HUMA |
|---|---|---|
| Price | $5.71 | $1.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $7.00 | ★ $10.13 |
| AVG Volume (30 Days) | 230.4K | ★ 4.9M |
| Earning Date | 11-07-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $89,422,000.00 | $1,571,000.00 |
| Revenue This Year | $3.46 | N/A |
| Revenue Next Year | $2.80 | $698.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.49 | N/A |
| 52 Week Low | $2.30 | $0.91 |
| 52 Week High | $6.63 | $5.48 |
Technical Indicators
Market Signals| Indicator | DIBS | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 40.84 |
| Support Level | $5.86 | $0.91 |
| Resistance Level | $6.13 | $1.17 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 11.76 | 35.90 |
Price Performance
Historical ComparisonAbout DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.